Drug law enforcement efforts receive ample funding each year while drug treatment options remain shamefully underfunded. Many people who seek help for their problematic drug use are unable to access treatment, encountering insurance barriers, months-long wait lists, or programs that don't meet their needs. Far too many people are only able to access drug treatment as a result of an arrest or criminal conviction. DPA advocates expanding drug treatment access to meet need, as well as broadening the definition of drug treatment to include models of care that incorporate harm reduction principles and prioritize health, safety, and improving quality of life over strict abstinence. We are changing the national dialogue around treatment by raising awareness about proven drug treatment models, like heroin assisted treatment, that have been researched and employed successfully abroad but are still not available in the United States. Through these efforts, we are laying the foundation for more diverse and effective drug treatment options.
If Signed by the Governor, this Legislation will Keep Families Together, Enhance Public Safety and Save the State Millions of Dollars
Santa Fe – Last night, the New Mexico State Legislature passed the Substance Abuse and Crime Prevention Act with overwhelming bi-partisan support. This bill proposes appropriate community-based treatment, instead of incarceration, for non-violent drug possession offenders and people with drug-related probation or parole violations. Senate Bill 321, sponsored by Senator Martinez and Representative Maestas, sailed through both the Senate and the House with a vote of 21-3 in the Senate and 41-26 in the House.
Latest Analysis: Drug Courts Have Not Demonstrated Cost Savings, Reduced Incarceration or Improved Public Safety
Washington, D.C. – At two briefings on Capitol Hill today, the Drug Policy Alliance released a groundbreaking new report, Drug Courts are Not the Answer: Toward a Health-Centered Approach to Drug Use, which finds that drug courts have not demonstrated cost savings, reduced incarceration, or improved public safety; leave many people worse off for trying; and have actually made the criminal justice system more punitive toward addiction – not less.
A New PATH is a non-profit advocacy organization of parents, concerned citizens, individuals in recovery, healthcare professionals and community leaders working together to educate the public, media and decision makers about the true nature of the disease of addiction, and to expand access to treatment services. We advocate to end discriminatory drug policies that serve as roadblocks to recovery.
H R T C is a nonprofit organization dedicated to providing alternative treatment to people with drug and alcohol problems. The treatment, Harm Reduction Psychotherapy, is based on the belief that substance abuse develops in each individual from a unique interaction of biological, psychological, and social factors.
ASAM is a professional society representing close to 3,000 physicians dedicated to increasing access and improving quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addictions.
The North American Opiate Medication Initiative (NAOMI)is a clinical trial that will test whether heroin-assisted therapy benefits people suffering from chronic opiate addictions who have not benefited from other treatments.
Funded by the Canadian Institutes of Health Research, Canada's premier funding agency for health research, and approved by Health Canada, the study is enrolled participants in Vancouver and Montreal
Since 1991, Join Together has supported community-based efforts to advance effective alcohol and drug policy, prevention, and treatment.
This volume includes a variety of perspectives on harm reduction approaches, together with an analysis of the concept's role within drug policies, both in Europe and beyond. Readers may not necessarily agree with all of the arguments made or the conclusiondrawn, but we hope it is perceived as a valuable contribution to the ongoing debate on how to respond to contemporary drug problems in Europe.
The International Centre for Science in Drug Policy (ICSDP) is an international network of scientists, academics, and health practitioners committed to improving the health and safety of communities and individuals affected by illicit drugs.